Mitochondrial Abnormalities and Synaptic Damage in Huntington’s Disease: a Focus on Defective Mitophagy and Mitochondria-Targeted Therapeutics is a research paper published in Molecular Neurobiology (2021). On theSindex it has a DataRank of 0. It has been cited 76 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
national institutes of health
Grant: AG042178
national institutes of health
Grant: AG047812
national institutes of health
Grant: NS105473
national institutes of health
Grant: AG060767
national institutes of health
Grant: AG069333
national institutes of health
Grant: AG066347
National Institutes of Health
Grant: 5R01NS105473-02
Mitochondrial Fragmentation and Neurodegeneration in Huntington's Disease
National Institutes of Health
Grant: 1R56AG066347-01A1
MicroRNA-455-3p and Alzheimer's Disease
National Institutes of Health
Grant: 5R01AG069333-04
Mitochondrial Molecules as Therapeutic Drugs for Alzheimer's Disease
National Institutes of Health
Grant: 7R03AG063162-02
Differential Expression of Brainstem Neurotransmitters in Alzheimer's Disease and Alzheimer's Dementia Related Diseases
National Institutes of Health
Grant: 7R01AG042178-04
Dynamin-Related Protein 1 and Mitochondrial Fragmentation in Alzheimer's Disease
National Institutes of Health
Grant: 1R01NS060767-01A1
Functional Regeneration and Sprouting of Respiratory Pathways After Spinal Cord I
National Institutes of Health
Grant: 5R01AG047812-05
Voltage-Dependent Anion Channel and Neurodegeneration in Alzheimer's Disease
FWCI
4.51
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Exploring the therapeutic potential of Sirt6-enriched adipose stem cell-derived exosomes in myocardial ischemia–reperfusion injury: unfolding new epigenetic frontiers
Additional file 1 of Exploring the therapeutic potential of Sirt6-enriched adipose stem cell-derived exosomes in myocardial ischemia–reperfusion injury: unfolding new epigenetic frontiers
Additional file 2 of Exploring the therapeutic potential of Sirt6-enriched adipose stem cell-derived exosomes in myocardial ischemia–reperfusion injury: unfolding new epigenetic frontiers
Additional file 2 of Exploring the therapeutic potential of Sirt6-enriched adipose stem cell-derived exosomes in myocardial ischemia–reperfusion injury: unfolding new epigenetic frontiers
Additional file 3 of Exploring the therapeutic potential of Sirt6-enriched adipose stem cell-derived exosomes in myocardial ischemia–reperfusion injury: unfolding new epigenetic frontiers
Additional file 3 of Exploring the therapeutic potential of Sirt6-enriched adipose stem cell-derived exosomes in myocardial ischemia–reperfusion injury: unfolding new epigenetic frontiers
Additional file 4 of Exploring the therapeutic potential of Sirt6-enriched adipose stem cell-derived exosomes in myocardial ischemia–reperfusion injury: unfolding new epigenetic frontiers
Additional file 4 of Exploring the therapeutic potential of Sirt6-enriched adipose stem cell-derived exosomes in myocardial ischemia–reperfusion injury: unfolding new epigenetic frontiers